Literature DB >> 1148660

Immune status of children with and without severe infection during remission of malignant disease.

J Graham-Pole, M L Willoughby, S Aitken, A Ferguson.   

Abstract

The immune status of children with malignant disease in remission was assessed usingvarious immune function tests. Children with infections had significantlymore neutropenia, hypogammaglobulinaemia, and impaired cell-mediated immune responses than those without. These two groups combined had much more absolute lymphopenia and impairment of both cell-mediated immunity and antibody-producing capacity thancontrol children with non-malignant conditions. Regular immunological evaluation isrecommended for children with malignant disease when new intensive treatment schedules are under trial and for individual patients particularly prone to develop infections during treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1148660      PMCID: PMC1673450          DOI: 10.1136/bmj.2.5969.467

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  15 in total

1.  T- and B-lymphocytes and lymphoblasts in untreated acute lymphocytic leukemia.

Authors:  L Borella; L Sen
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

2.  Expression of cell surface markers on T and B lymphocytes after long-term chemotherapy of acute leukemia.

Authors:  L Sen; L Borella
Journal:  Cell Immunol       Date:  1973-10       Impact factor: 4.868

3.  Fatalities during remission of childhood leukemia.

Authors:  J V Simone; E Holland; W Johnson
Journal:  Blood       Date:  1972-06       Impact factor: 22.113

4.  Impaired lymphocyte transformation in leukemic patients after intensive therapy.

Authors:  G B Humphrey; M E Nesbit; K K Chary; W Krivit
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

5.  PHA -blastogenesis in relationship to the cell-type and source in acute leukemia.

Authors:  G Astaldi; L Massimo; F Dagna; P G Mori; A Fossati
Journal:  Blut       Date:  1972-03

6.  Oncologists' reply: survival expectancy in acute lymphocytic leukemia.

Authors:  J F Holland; O Glidewell
Journal:  N Engl J Med       Date:  1972-10-12       Impact factor: 91.245

7.  Cyclic chemotherapy in acute lymphoblastic leukaemia of childhood: 5-year survivals.

Authors:  M R Vowels; M L Willoughby
Journal:  Arch Dis Child       Date:  1973-06       Impact factor: 3.791

8.  Infection during induction of remission in acute lymphocytic leukemia.

Authors:  W T Hughes; D R Smith
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

9.  The millipore filter assay technique for measuring tritiated thymidine incorporation into DNA in leucocyte cultures.

Authors:  J H Robbins; J J Gart; W R Levis; P G Burk
Journal:  Clin Exp Immunol       Date:  1972-08       Impact factor: 4.330

10.  The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission.

Authors:  L Borella; R G Webster
Journal:  Cancer Res       Date:  1971-04       Impact factor: 12.701

View more
  2 in total

1.  Familial dysequilibrium-diplegia with T-lymphocyte deficiency.

Authors:  J Graham-Pole; A Ferguson; A A Gibson; J B Stephenson
Journal:  Arch Dis Child       Date:  1975-12       Impact factor: 3.791

2.  Bronchiectasis in acute leukaemia.

Authors:  P J Kearney; C R Kershaw; P A Stevenson
Journal:  Br Med J       Date:  1977-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.